Verrica Pharmaceuticals (VRCA) Stock Chart & Stock Price History $0.44 +0.01 (+2.12%) Closing price 04:00 PM EasternExtended Trading$0.40 -0.04 (-8.41%) As of 07:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Verrica Pharmaceuticals Stock Price Performance 5 Day Performance-0.52%1 Month Performance-31.87%3 Month Performance-36.83%6 Month Performance-69.50%Year-To-Date Performance-36.83%1 Year Performance-92.53% Receive VRCA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Verrica Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address VRCA Stock Chart for Monday, March, 31, 2025 VRCA Chart by TradingViewRemove Ads Verrica Pharmaceuticals Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization03/31/2025$0.43$0.44+2.12%$0.45$0.39532,755 shs$40.59 million03/28/2025$0.44$0.43-1.03%$0.47$0.42392,815 shs$39.74 million03/27/2025$0.44$0.44-1.57%$0.47$0.43249,367 shs$40.15 million03/26/2025$0.48$0.44-6.75%$0.49$0.42608,897 shs$40.80 million03/25/2025$0.52$0.48-8.70%$0.55$0.46664,034 shs$43.75 million03/24/2025$0.56$0.52-6.43%$0.61$0.50540,426 shs$47.92 million03/21/2025$0.61$0.56-8.51%$0.66$0.562.62 million shs$25.45 million03/20/2025$0.62$0.61-1.71%$0.63$0.59359,421 shs$27.81 million03/19/2025$0.65$0.62-4.54%$0.67$0.60272,808 shs$28.30 million03/18/2025$0.65$0.65-0.08%$0.68$0.60517,116 shs$29.64 million Get the Latest News and Ratings for VRCA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Verrica Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 03/17/2025$0.54$0.65+21.07%$0.66$0.51634,103 shs$29.66 million03/14/2025$0.59$0.54-9.10%$0.59$0.54391,458 shs$24.50 million03/13/2025$0.60$0.59-1.35%$0.62$0.56301,107 shs$26.96 million03/12/2025$0.65$0.60-7.56%$0.63$0.54786,116 shs$27.32 million03/11/2025$0.64$0.65+1.76%$0.68$0.61401,524 shs$29.56 million03/10/2025$0.61$0.64+4.77%$0.65$0.59452,827 shs$29.05 million03/07/2025$0.62$0.61-1.71%$0.65$0.58208,016 shs$27.73 million03/06/2025$0.63$0.62-1.26%$0.64$0.60160,886 shs$28.21 million03/05/2025$0.62$0.63+0.82%$0.63$0.59410,399 shs$28.57 million03/04/2025$0.64$0.62-2.92%$0.65$0.58377,559 shs$28.34 million03/03/2025$0.65$0.64-1.39%$0.69$0.62550,694 shs$29.19 million02/28/2025$0.59$0.65+10.00%$0.71$0.59367,256 shs$29.60 million Related Companies AMRN Stock Price Chart TNGX Stock Price Chart OCGN Stock Price Chart KOD Stock Price Chart CGC Stock Price Chart ACRS Stock Price Chart RZLT Stock Price Chart FDMT Stock Price Chart ALMS Stock Price Chart MDWD Stock Price Chart Receive VRCA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Verrica Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:VRCA) was last updated on 3/31/2025 by MarketBeat.com Staff From Our PartnersA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTrump’s Great Society Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Verrica Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Verrica Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
